85 Biggest Movers From Yesterday

Gainers

• Fulcrum Therapeutics, Inc. FULC jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
• Lightning eMotors, Inc. ZEV shares climbed 81% to settle at $11.60 after the company reported a multi-year deal with Forest River for zero-emission bus technology, charging products and services. The deal is valued at up to $850 million.
• SC Health Corporation SCPE gained 53.1% to close at $16.00.
• MediaCo Holding Inc. MDIA climbed 36.3% to settle at $10.10.
• Eliem Therapeutics, Inc. ELYM gained 27.2% to close at $15.90 as the company priced its IPO at $12.50 per share.
• Exagen Inc. XGN jumped 24.6% to close at $12.77 following upbeat Q2 results.
• Orphazyme A/S ORPH gained 24.6% to close at $5.22.
• Achilles Therapeutics plc ACHL shares surged 22.1% to settle at $7.56 following Q2 results.
• Fisker Inc. FSR rose 21.6% to close at $18.27. Morgan Stanley resumed covered on the stock with a Buy rating and a $40 price target and set its bull-case scenario at $90.
• Cortexyme, Inc. CRTX gained 21.5% to settle at $120.21. Cortexyme recently announced Q2 earnings results and provided a business update.
• 3D Systems Corporation DDD shares surged 21.5% to close at $34.44 after the company reported better-than-expected results for its second quarter on Monday.
• ABVC BioPharma, Inc. ABVC gained 18.4% to close at $3.73 on abnormally-high volume.
• NexImmune, Inc. NEXI surged 18.1% to settle at $12.46 following Q2 results.
• Agrify Corporation AGFY climbed 17.7% to settle at $26.62. Agrify is expected to report its financial results for the second quarter on August 12, 2021.
• Angion Biomedica Corp. ANGN gained 17.6% to close at $12.61. Angion Biomedica recently announced positive results from its Phase 1 study in healthy volunteers for ANG-3070 for fibrotic diseases.
• BRP Group, Inc. BRP gained 17.6% to close at $32.60 after the company reported better-than-expected Q2 results.
• Albertsons Companies, Inc. ACI rose 17.2% to close at $29.05 after the company said Sharon McCollam will join the Company as its President and Chief Financial Officer.
• Nuwellis, Inc. NUWE gained 16.8% to settle at $4.60 after reporting quarterly results.
• Pioneer Power Solutions, Inc. PPSI jumped 16.7% to close at $4.67.
• Moving iMage Technologies, Inc. MITQ rose 16.4% to settle at $3.83.
• Myomo, Inc. MYO gained 16.3% to close at $9.13 after reporting upbeat Q2 results.
• Pixelworks, Inc. PXLW jumped 15.4% to close at $3.52. Pixelworks is expected to release its Q2 financial results on August 10, 2021 after the closing bell.
• Janus International Group, Inc. JBI gained 14.8% to settle at $15.08 after the company reported Q2 sales of $174.18 million, up from $122.23 million year over year.
• Cyxtera Technologies, Inc. CYXT rose 14.6% to close at $9.74. The company recently announced Q2 results.
• Xenetic Biosciences, Inc. XBIO gained 13.8% to close at $3.94.
• Evolv Technologies Holdings, Inc. EVLV rose 13.8% to close at $9.51. Evolv Technologies is expected to release Q2 results on August 16, 2021.
• MyMD Pharmaceuticals, Inc. MYMD gained 13.8% to close at $5.46. MyMD Pharmaceuticals’ subsidiary Oravax Medical is preparing to commence clinical trials for oral Covid-19 vaccine.
• Moxian, Inc MOXC rose 13.6% to close at $7.96.
• Harmony Biosciences Holdings, Inc. HRMY gained 12.7% to close at $30.16 after reporting upbeat quarterly results. Harmony Biosciences and Blackstone entered into Strategic financing collaboration for up to $330 million.
• TimkenSteel Corporation TMST rose 11.2% to close at $16.88.
• Lithium Americas Corp. LAC jumped 11.1% to close at $17.18.
• Array Technologies, Inc. ARRY rose 10.7% to close at $15.18. Roth Capital analyst Philip Shen upgraded Array Technologies to Buy from Neutral with a $25 price target, implying an upside of 82.3%.
• AerSale Corporation ASLE gained 10.6% to close at $12.83. AerSale, last week, reported second-quarter revenue growth of 102.7% year-over-year to $91.91 million, beating the consensus of $77.28 million.
• Express, Inc. EXPR rose 10.3% to close at $6.31.
• Model N, Inc. MODN gained 10.1% to close at $35.88 after the company reported upbeat Q3 results and issued strong Q4 forecast.
• Dynatronics Corporation DYNT climbed 8.5% to close at $1.41 after the company reported strong preliminary sales for the fourth quarter.
• The Trade Desk, Inc. TTD climbed 7.6% to close at $87.53. Several analysts raised their price targets on Trade Desk.
• Kansas City Southern KSU rose 7.5% to close at $289.75 following a report suggesting Canadian Pacific plans a new higher bid for the company, near $300 per share.
• Purple Innovation, Inc. PRPL rose 7.4% to close at $26.57 after the company swung to a profit in the second quarter. The company also issued FY21 sales guidance.
• Calliditas Therapeutics AB CALT gained 7% to close at $31.68. The FDA granted Fast Track Designation to Calliditas Therapeutics lead NOX inhibitor candidate setanaxib for primary biliary cholangitis (PBC).
• Lufax Holding Ltd LU rose 6.4% to close at $7.96 after reporting upbeat quarterly earnings.
• Allied Healthcare Products, Inc. AHPI shares gained 6.2% to close at $10.75 after jumping around 23% on Monday.
• Turning Point Therapeutics, Inc. TPTX rose 5.6% to close at $65.57 following Q2 earnings.
• Arcturus Therapeutics Holdings Inc. ARCT shares gained 4.9% to close at $50.58 after the company reported better-than-expected Q2 earnings and also said ARCT-021 will begin multinational placebo-controlled Phase 3 efficacy study funded & sponsored by a global entity.

Check out these big penny stock gainers and losers

Losers

• Katapult Holdings, Inc. KPLT shares tumbled 56.2% to close at $4.26 on Tuesday after the company reported Q2 earnings results.
• Impel NeuroPharma, Inc. IMPL fell 25.9% to close at $19.37. The company recently reported publication of pivotal Phase 3, open-label Stop 301 study of INP104 (TRUDHESA) for treatment of acute migraine in The Journal Headache.
• SmileDirectClub, Inc. SDC fell 24.2% to close at $5.08 after the company reported worse-than-expected Q2 results and issued FY21 sales guidance below estimates.
• Waitr Holdings Inc. WTRH dropped 23.3% to close at $1.22 after the company reported downbeat Q2 results. The company also reported the purchase of ProMerchant LLC, Cape Cod Merchant Services LLC and Flow Payments LLC.
• Metromile, Inc. MILE shares fell 22.5% to settle at $5.40 after the company reported a wider-than-expected Q2 loss.
• comScore, Inc. SCOR declined 22.5% to close at $3.12 after the company reported a wider-than-expected Q2 loss.
• Stereotaxis, Inc. STXS fell 21.3% to settle at $7.15 after the company reported Q2 earnings results.
• Sphere 3D Corp. ANY dropped 20.7% to close at $4.28 amid profit taking after the stock surged in recent sessions following last week's news the company will acquire exclusive rights for the assignment of cryptocurrency mining assets.
• EyeGate Pharmaceuticals, Inc. EYEG shares dropped 20.5% to close at $1.8050 after the company announced a $10.75 million registered direct offering priced at-the-market under Nasdaq rules.
• PARTS iD, Inc. ID fell 19.7% to close at $5.79 following weaker-than-expected Q2 results.
• Yalla Group Limited YALA shares dropped 18.9% to close at $10.99 following weak quarterly sales.
• Talkspace, Inc. TALK declined 18.7% to close at $4.82 following Q2 loss.
• Reata Pharmaceuticals, Inc. RETA dipped 18.1% to close at $100.00 after the company reported Q2 earnings and provided an update on clinical development programs.
• The RealReal, Inc. REAL fell 18% to close at $13.31 after the company reported worse-than-expected Q2 results.
• Liminal BioSciences Inc. LMNL fell 17.8% to close at $3.00. Liminal BioSciences jumped around 28% on Monday as the company said its subsidiary Prometic Biotherapeutics Inc. entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher for USD105 million.
• Mercurity Fintech Holding Inc. MFH dropped 17% to settle at $3.42 amid a rise in yields, which has weighed on tech and growth stocks.
• Casper Sleep Inc. CSPR declined 16.8% to close at $5.76 after reporting a wider-than-expected quarterly loss.
• Lucira Health, Inc. LHDX fell 16.8% to settle at $8.25.
• Star Equity Holdings, Inc. STRR fell 16.2% to close at $3.00 after the company posted a wider quarterly loss.
• ZIOPHARM Oncology, Inc. ZIOP declined 162.% to settle at $1.92 after the company reported Q2 earnings results. Following earnings, Raymond James downgraded the stock from Outperform to Market Perform and announced a $3 price target.
• SCWorx Corp. WORX fell 16% to settle at $3.21.
• Washington Prime Group Inc. WPG fell 15.5% to settle at $1.42 after the company reported Q2 earnings results.
• AeroCentury Corp. ACY dropped 15% to close at $17.07.
• CarLotz, Inc. LOTZ fell 14.3% to close at $4.03 after the company reported it withdrew previously-issued FY21 guidance, citing "channel constraints."
• FedNat Holding Company FNHC dipped 14.1% to close at $2.19 after reporting a wider quarterly loss.
• BioCryst Pharmaceuticals, Inc. BCRX shares fell 13.9% to close at $15.21 after the company announced it commenced a public offering of $200 million of common stock and pre-funded warrants.
• X Financial XYF dropped 13.9% to close at $6.81 following Q2 results.
• UpHealth, Inc. UPH fell 13.5% to close at $5.38. UpHealth is expected to release quarterly results on August 12, 2021.
• Home Point Capital Inc. HMPT dropped 13.5% to close at $4.56 after reporting a Q2 loss.
• Nano-X Imaging Ltd. NNOX fell 13.4% to settle at $26.07 after the company reported Q2 results and announced plans to acquire Zebra Medical Vision.
• Oak Street Health, Inc. OSH fell 12.9% to settle at $54.81 after the company reported worse-than-expected Q2 EPS results.
• Origin Agritech Limited SEED fell 12.5% to settle at $11.83.
• CareMax, Inc. CMAX fell 12% to settle at $8.35.
• Aterian, Inc. ATER dipped 11.5% to close at $4.86. Aterian S-1 showed registration for 2.7 million share common stock offering via selling shareholders. Roth Capital downgraded Aterian from Buy to Neutral and announced a $5.5 price target.
• Fulgent Genetics, Inc. FLGT shares slipped 11.3% to close at $97.34 after the company reported worse-than-expected Q2 results. Fulgent Genetics and Helio Health also reported a partnership to commercialize early cancer detection tests.
• Inovio Pharmaceuticals, Inc. INO fell 10.8% to settle at $8.57 after the company reported worse-than-expected Q2 results.
• AudioEye, Inc. AEYE fell 7.8% to close at $13.33. The company is expected to release quarterly earnings on August 11, 2021.
• Vuzix Corporation VUZI fell 7.2% to close at $12.73 after the company reported worse-than-expected Q2 results.
• Senseonics Holdings, Inc. SENS shares fell 6.5% to close at $3.04 after the company reported Q2 earnings results and issued FY21 guidance.
• Cano Health, Inc. CANO fell 6.2% to close at $10.94.
• Nautilus, Inc. NLS fell 5.4% to close at $13.56. Nautilus reported first-quarter FY22 sales growth of 61.7% year-on-year. Craig-Hallum downgraded Nautilus from Buy to Hold.